AcelRx Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
TLPH
CUSIP
00444T209
Type
Equity
Class
COM NEW
Num filings
33
Total reported value, excl. options
$2.43 M
Manager Report Date Value ($000) Shares Option Type